Viking Therapeutics (VKTX) News Today $32.68 +0.11 (+0.34%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$32.55 -0.13 (-0.40%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VKTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Short Interest in Viking Therapeutics, Inc. (NASDAQ:VKTX) Expands By 88,996.6%1 hour ago | marketbeat.comIs Viking Therapeutics the Next Big Biotech Bet?August 1 at 8:16 PM | fool.comAllianz Asset Management GmbH Sells 35,986 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)August 1 at 6:54 AM | marketbeat.comViking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 TrialJuly 31 at 11:49 AM | finance.yahoo.comViking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 TrialJuly 31 at 11:49 AM | insidermonkey.comTCW Group Inc. Boosts Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 29, 2025 | marketbeat.comMediolanum International Funds Ltd Makes New Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 29, 2025 | marketbeat.comBrokerages Set Viking Therapeutics, Inc. (NASDAQ:VKTX) Target Price at $86.92July 29, 2025 | americanbankingnews.comQ3 EPS Forecast for Viking Therapeutics Reduced by AnalystJuly 29, 2025 | americanbankingnews.comQ3 EPS Estimate for Viking Therapeutics Lowered by AnalystJuly 29, 2025 | americanbankingnews.comFY2025 EPS Estimates for VKTX Reduced by Cantor FitzgeraldJuly 28, 2025 | americanbankingnews.comFY2025 EPS Forecast for Viking Therapeutics Cut by AnalystJuly 28, 2025 | marketbeat.comLeerink Partnrs Issues Negative Outlook for VKTX EarningsJuly 28, 2025 | americanbankingnews.comHC Wainwright Expects Lower Earnings for Viking TherapeuticsJuly 28, 2025 | marketbeat.comEquities Analysts Offer Predictions for VKTX Q3 EarningsJuly 28, 2025 | marketbeat.comWilliam Blair Issues Pessimistic Estimate for VKTX EarningsJuly 28, 2025 | marketbeat.comY Intercept Hong Kong Ltd Takes $674,000 Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 27, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for VKTX FY2029 Earnings?July 27, 2025 | americanbankingnews.comViking Therapeutics’ Earnings Call: Clinical Advances Amid Financial ChallengesJuly 26, 2025 | theglobeandmail.comMaxim Group Sticks to Its Buy Rating for Viking Therapeutics (VKTX)July 26, 2025 | theglobeandmail.comFY2029 EPS Estimates for VKTX Reduced by Leerink PartnrsJuly 26, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Rating of "Buy" from BrokeragesJuly 26, 2025 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX)July 25, 2025 | theglobeandmail.comViking Therapeutics (NASDAQ:VKTX) Price Target Cut to $122.00 by Analysts at Raymond James FinancialJuly 25, 2025 | marketbeat.comCitigroup Issues Positive Forecast for Viking Therapeutics (NASDAQ:VKTX) Stock PriceJuly 25, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Down After Earnings MissJuly 25, 2025 | marketbeat.comViking Therapeutics Q2: Confidently Continuing The RecoveryJuly 25, 2025 | seekingalpha.comViking Therapeutics (NASDAQ:VKTX) Releases Quarterly Earnings ResultsJuly 24, 2025 | marketbeat.comViking Therapeutics, Inc. (VKTX): A Bull Case TheoryJuly 24, 2025 | insidermonkey.com1492 Capital Management LLC Makes New $992,000 Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 24, 2025 | marketbeat.comViking Therapeutics, Inc. (VKTX) Q2 2025 Earnings Call TranscriptJuly 23, 2025 | seekingalpha.comViking Therapeutics Posts Wider Q2 LossJuly 23, 2025 | fool.comViking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateJuly 23, 2025 | prnewswire.comBank of New York Mellon Corp Has $12.52 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 21, 2025 | marketbeat.com3 Monster Stocks in the Making to Buy Right NowJuly 20, 2025 | fool.comThese 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?July 20, 2025 | fool.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Formidable Asset Management LLCJuly 19, 2025 | marketbeat.comAfter Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.July 19, 2025 | fool.comViking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025July 16, 2025 | prnewswire.comH.C. Wainwright Reiterates a Buy Rating on Viking Therapeutics (VKTX), Sets a $102 PTJuly 16, 2025 | insidermonkey.comKintayl Capital LP Grows Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 16, 2025 | marketbeat.comViking Therapeutics (VKTX) Projected to Post Quarterly Earnings on WednesdayJuly 16, 2025 | marketbeat.comThe Best Stocks to Invest $1,000 In Right NowJuly 15, 2025 | fool.comConcurrent Investment Advisors LLC Buys New Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 13, 2025 | marketbeat.comPrincipal Financial Group Inc. Sells 30,629 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)July 13, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Caas Capital Management LPJuly 11, 2025 | marketbeat.comBanque Pictet & Cie SA Takes Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 11, 2025 | marketbeat.comU.S. Capital Wealth Advisors LLC Sells 8,423 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)July 10, 2025 | marketbeat.comViking Therapeutics (VKTX) Soars 9.7% on Looming Weight Loss Drug Trial ResultsJuly 9, 2025 | insidermonkey.comFinancial Counselors Inc. Acquires 16,823 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)July 9, 2025 | marketbeat.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.030.45▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼3316▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Madrigal Pharmaceuticals News Today Eli Lilly and Company News Today Genmab A/S News Today Moderna News Today Dr. Reddy's Laboratories News Today Qiagen News Today Viatris News Today Ascendis Pharma A/S News Today Verona Pharma PLC American Depositary Share News Today BridgeBio Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
